Zobrazeno 1 - 10
of 1 101
pro vyhledávání: '"CONSOLIDATION THERAPY"'
Use of durvalumab in stage III non‐small‐cell lung cancer based on eligibility for the PACIFIC study
Publikováno v:
Thoracic Cancer, Vol 14, Iss 6, Pp 563-572 (2023)
Abstract Background Durvalumab following concurrent chemoradiotherapy is standard treatment for unresectable stage III non‐small‐cell lung cancer based on the results of the PACIFIC trial. Based on trial criteria, not all patients are eligible fo
Externí odkaz:
https://doaj.org/article/de8ab8e7c4494ea6ac65ab47f625f241
Publikováno v:
Cancer & Metabolism, Vol 11, Iss 1, Pp 1-10 (2023)
Abstract Acute lymphoblastic leukemia (ALL) and its treatment continue to pose substantial risks. To understand ALL more deeply, the metabolome in fasting plasma of 27 ALL patients before and after high-dose methotrexate therapies (consolidation ther
Externí odkaz:
https://doaj.org/article/4ff0739fac8e4b9cb6bea4230659a76f
Autor:
Juwhan Choi, Jeong Eun Lee, Chang‐Min Choi, In‐Jae Oh, Kye Young Lee, Tae Won Jang, Seung Hyeun Lee, Eun Young Kim, Dong Won Park, Sun Hyo Park, Sung Yong Lee
Publikováno v:
Thoracic Cancer, Vol 13, Iss 23, Pp 3431-3435 (2022)
Abstract Introduction The PACIFIC study demonstrated that durvalumab consolidation therapy significantly improved progression‐free survival (PFS) and overall survival (OS) in patients with unresectable stage III non‐small cell lung cancer (NSCLC)
Externí odkaz:
https://doaj.org/article/5ba822ad74f0492ebeb9231d6ed64841
Autor:
Hiroyuki Muranushi, Junya Kanda, Masayuki Kobayashi, Takeshi Maeda, Toshiyuki Kitano, Masaaki Tsuji, Yasunori Ueda, Takayuki Ishikawa, Masaharu Nohgawa, Mitsumasa Watanabe, Kazunori Imada, Toshinori Moriguchi, Mitsuru Itoh, Hitoshi Ohno, Akihito Yonezawa, Hirokazu Hirata, Nobuyoshi Arima, Kohsuke Asagoe, Naoyuki Anzai, Kayoko Nagata, Shinji Yasuno, Yoshihiro Kuwabara, Hiromi Kitao, Ihhwa Kim, Kiyomi Kawagishi, Kenji Ueshima, Shinjiro Tominari, Takeo Nakayama, Kouhei Yamashita, Akifumi Takaori-Kondo
Publikováno v:
Hematology, Vol 27, Iss 1, Pp 239-248 (2022)
Objectives: We conducted a phase II trial to prospectively evaluate the efficacy and safety of bortezomib-cyclophosphamide-dexamethasone (VCD) induction, autologous stem cell transplantation (ASCT), VCD consolidation, and bortezomib maintenance in tr
Externí odkaz:
https://doaj.org/article/be9c1f85b3ab4539bb46b8a6ed1b4f86
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ya-Fang Ma, Ying Lu, Qian Wu, Yin-Jun Lou, Min Yang, Jie-Yu Xu, Cai-Hong Sun, Li-Ping Mao, Gai-Xiang Xu, Li Li, Jian Huang, Huai-Yu Wang, Li-Jiang Lou, Hai-Tao Meng, Jie-Jing Qian, Wen-Juan Yu, Ju-Ying Wei, Zhen-Yu Li, Xue-Lu Zhu, Xiao-Yan Yan, Su-Ning Chen, Jie Jin, Hong-Hu Zhu
Publikováno v:
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-4 (2022)
Abstract Acute promyelocytic leukemia (APL) has become curable over 95% patients under a complete chemo-free treatment with all-trans retinoic acid (ATRA) and arsenic trioxide in low-risk patients. Minimizing chemotherapy has proven feasible in high-
Externí odkaz:
https://doaj.org/article/9e1afc1ec526406a8c346c5650526aed
Publikováno v:
Neurology International, Vol 14, Iss 3, Pp 574-580 (2022)
Primary central nervous system lymphoma (PCNSL) is a rare and aggressive disease that originates from lymphocytes and develops in the central nervous system. There is no standard consolidation/maintenance therapy for PCNSL. While there exists a varie
Externí odkaz:
https://doaj.org/article/c72f4ac0bc3144c7bc45a87a4451d6f0
Publikováno v:
Leukemia Research Reports, Vol 19, Iss , Pp 100368- (2023)
Thirty patients with newly diagnosed symtomatic MM (multiple myeloma) received ASCT (autologous stem cell transplantation) and two cycles of bortezomib-cyclophosphamide-dexamethasone as consolidation treatment followed by maintenance of bortezomib fo
Externí odkaz:
https://doaj.org/article/66c8965569204737a5c6819fcb2c3667
Autor:
Vahid Alipour, Soroush Rad, Shahin Nargesi, Fateme Mezginejad, Reza Jahangiri, Zeinab Dolatshahi, Seyed Asadollah Mousavi, Zahra Moshkani
Publikováno v:
Iranian Journal of Public Health, Vol 51, Iss 11 (2022)
Background: Cancer imposes a significant economic burden on the health system and society. Acute myeloid leukemia (AML) is the third deadliest leukemia and is one of the leading health problems worldwide. The present study aimed to estimate the econo
Externí odkaz:
https://doaj.org/article/17d3213a877e43f3a1575264064b9145
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.